SRS Therapeutics Private Limited
About SRS Therapeutics Private Limited
Data last updated:
SRS Therapeutics Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Srs Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85191MH2006PTC161490. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Yeva Therapeutics Private Limited. It is led by directors Suchet Shyamsunder Rastogi and Rajan Dubey.
Its last annual general meeting (AGM) was held on 19 August 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080.
As per the financials filed for FY 2021, the company reported a revenue of ₹17.38 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.03 Lakh (net margin -11.7%) and EBITDA of -₹2.03 Lakh (EBITDA margin -11.7%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
SRS Therapeutics Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080
- IndustryPharma, Drug Formulation & Development
To see the full contact details of SRS Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of SRS Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of SRS Therapeutics Private Limited, buy the company report.
Financials of SRS Therapeutics Private Limited
FY 2021 filings availableSRS Therapeutics Private Limited reported revenue of ₹17.38 Lakh (up 234% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 234% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 46%. EBITDA fell 142% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹17.38 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.7% | ||||
| Net Profit Margin | -11.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SRS Therapeutics Private Limited, buy the company report.
Board of directors of SRS Therapeutics Private Limited
SRS Therapeutics has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suchet Shyamsunder Rastogi Also directs: SRS Unistraw Private Limited, Clesstra Healthcare Private Limited, SRS Pharmaceuticals Private Limited and 3 more | Director | 28 Apr 2006 | 20 Years 6 Months | Current |
| Rajan Dubey Also directs: SRS Unistraw Private Limited, Clesstra Healthcare Private Limited, Unitex Tenamyd Canada Private Limited and 5 more | Director | 06 Feb 2020 | 6 Years 8 Months | Current |
Auditor
SRS Therapeutics Private Limited is audited by M SHETH & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M SHETH & CO | FY 2021 | 116371W |
Shareholding
The shareholding of SRS Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SRS Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving SRS Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SRS Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
SRS Therapeutics has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of SRS Therapeutics Private Limited, buy the company report.
Recent activity
SRS Therapeutics Private Limited has 6 board changes on record since 2006: 2 appointments and 4 cessations. The latest: Rajan Dubey ceased to be Additional Director on 30 Dec 2020.
Frequently asked questions
SRS Therapeutics is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 2006 (20+ years old) and is registered under CIN U85191MH2006PTC161490.
SRS Therapeutics has 2 current directors:
- Suchet Shyamsunder Rastogi - Director
- Rajan Dubey - Director
The latest financial statements of SRS Therapeutics on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 19 August 2021. Year-wise statements from 2015 are in the company report.
No. SRS Therapeutics has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of SRS Therapeutics is U85191MH2006PTC161490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SRS Therapeutics was incorporated on 28 April 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Rajan Dubey ceased to be Additional Director on 30 Dec 2020. Rajan Dubey was appointed as Director on 06 Feb 2020. Aman Singh Siwach ceased to be Director on 01 Feb 2020. SRS Therapeutics has 6 board changes on record in total.
The registered office of SRS Therapeutics is at 504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080.
SRS Therapeutics operates in the pharma industry, in the drug formulation and development segment.
The compliance status of SRS Therapeutics is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.